C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
167/179, 260/312
C07C 59/40 (2006.01) C07C 43/178 (2006.01) C07C 43/225 (2006.01) C07C 57/58 (2006.01) C07C 59/66 (2006.01) C07C 59/68 (2006.01) C07D 257/04 (2006.01) C07D 257/06 (2006.01) C07D 295/088 (2006.01)
Patent
CA 1242195
Abstract This invention provides novel compounds which are leukotriene antagonists, certain novel intermedi- ates to the compounds, formulations of the compounds, and a method of using the compounds for the treatment of conditions characterized by an excessive release of leukotrienes. The novel compounds are of the general formula Image I or a pharmaceutically acceptable salt thereof, wherein: R1 is Image or halo; R2 is halo or hydroxy; R3 is C1-C12 alkyl, hydroxy-substituted C1-C12 alkyl, or C2-C6 alkenyl; Y is -O-, Image or -CR6R7-; Z is -O-, Image or -CR8R9, or when taken together, -Y-Z is -CH=C. n is 1-10; D is CN, SCN or QR4; Image or a bond; R4 is -COR10, hydroxy, -NR11R12, -SC(=NH)NH2, or Image where R is hydrogen or C1-C3 alkyl; R5 is hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, or phenyl optionally substituted with halo, C1-C4 alkyl, or C1-C4 alkoxy; each of R6, R7, R8, and R9 is independently hydrogen, C1-C10 alkyl, phenyl, or benzyl; R10 is hydroxy, C1-C4 alkoxy, -NHOH, or -NR11R12; each of R11 and R12 is independently hydrogen, C1-C3 alkyl, or when taken together with the nitrogen atom form a morpholine or N-methyl piperazine ring; and p is 0, 1, or 2; with the provisions that: a) when R1 is R5-?- R2 may not be hydroxy; b) when one of Y and Z is -O- or Image , the other of Y and Z may not be -O- or Image ; and c) when R is COR10, hydroxy, -NR11R12, or -SC(=NH)NH2, Q may only be a bond.
458595
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1339467